Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Tramadol Versus Placebo in the Management of Postoperative Pain Following Bunionectomy

ClinicalTrials.gov ID: NCT03290378

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03290378. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 18, 2026, 7:03 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Double Blind, Three-Arm Study to Evaluate the Efficacy and Safety of Tramadol Infusion (AVE-901) Versus Placebo in the Management of Postoperative Pain Following Bunionectomy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study evaluates the effectiveness and safety of IV tramadol compared to placebo managing postoperative pain following a bunionectomy

Study identification

NCT ID
NCT03290378
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Avenue Therapeutics, Inc.
Industry
Enrollment
409 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 19, 2017 (Actual)
Primary completion
Apr 11, 2018 (Actual)
Completion
Apr 23, 2018 (Actual)
Last update posted
Mar 19, 2020

2017 – 2018

United States locations

U.S. sites
5
U.S. states
3
U.S. cities
5
Facility City State ZIP Site status
Trovare Clinical Research Bakersfield California 93301 —
Lotus Clinical Research Pasadena California 91105 —
Cheseapeake Research Group, LLC Pasadena Maryland 21122 —
H.D. Research Corporation Houston Texas 77004 —
Endeavor Clinical Trials, PA San Antonio Texas 78229 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03290378, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 19, 2020 · Synced Nov 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.